Related Experiment Video
Updated: Aug 8, 2026
A Component-resolved Diagnostic Approach for a Study on Grass Pollen Allergens in Chinese Southerners with Allergic Rhinitis and/or Asthma
Published on: June 4, 2017
The first fully automated allergy analyser UniCAP: comparison with IMMULITE for allergy panel testing
1Department of Clinical Chemistry, Maaslandziekenhuis, Sittard, The Netherlands.
Insights
The UniCAP System demonstrated superior clinical and logistical performance compared to the IMMULITE System for allergy testing. UniCAP showed higher sensitivity and specificity in both inhalant and food allergy screening, offering a more convenient workflow.
Area of Science:
- Clinical diagnostics
- Immunology
- Allergy testing
Background:
- Automated immunoassay systems are crucial for reliable allergy diagnosis.
- Evaluating system convenience, flexibility, and result reliability is essential.
- Comparison between UniCAP and IMMULITE systems for allergy screening.
Purpose of the Study:
- To compare the performance of the UniCAP System against the IMMULITE System for allergy diagnosis.
- To assess the clinical and logistical convenience of both automated immunoassay systems.
- To evaluate sensitivity and specificity of inhalant and food allergy screening tests.
Main Methods:
- Comparative study of UniCAP (Phadiatop) and IMMULITE (AlaTOP) for inhalant allergy.
- Comparison of UniCAP (fx5) and IMMULITE (fp5) for food allergy screening.
- Analysis of test results concordance with clinical diagnosis and follow-up testing.
Main Results:
- Phadiatop (UniCAP) showed 96% sensitivity and 92% specificity for inhalant allergy.
- AlaTOP (IMMULITE) showed 86% sensitivity and 94% specificity for inhalant allergy.
- UniCAP demonstrated closer agreement between screening and follow-up results for both inhalant and food allergies, with better logistical convenience.
Conclusions:
- The UniCAP System appears to be superior to the IMMULITE System both logistically and clinically for allergy testing.
- UniCAP offers improved reliability and convenience in automated immunoassay systems for allergy diagnosis.
- The study highlights UniCAP's advantages in sensitivity, specificity, and workflow efficiency.
Abstract:
Automated immunoassay systems should be convenient to handle, flexible and give reliable results. To investigate the extent to which the UniCAP System met the above requirements, compared with the IMMULITE System, we compared the Phadiatop (UniCAP) and AlaTOP (IMMULITE) results of 110 patients with positive clinical diagnoses for inhalant allergy. In addition, we compared food screening test results of 103 patients with a clinical positive diagnosis for food, and 110 test results of controls with negative diagnosis for allergy. Phadiatop had a sensitivity of 96% and a specificity of 92%. AlaTOP had a sensitivity of 86% and a specificity of 94%. For food screening the results were: 75% sensitivity and 82% specificity for fx5 (UniCAP) and 63% sensitivity and 71% specificity for fp5 (IMMULITE). Furthermore, those samples for which the test results which were not in concordance with the clinical diagnosis were tested with the follow-up panel of the different screening tests. For the AlaTOP follow-up we had to use the DPC microplate System (Milenia), because single allergen testing is not yet possible on the IMMULITE System. With regard to sensitivity, the UniCAP specific inhalant allergen tests and the original Phadiatop results showed closer agreement with each other than did the Milenia specific allergen results with the AlaTOP. The specificity of the single inhalant allergen tests was the same for both systems. For food allergy testing the UniCAP System shows closer agreement between the screening and the follow-up results than does the IMMULITE. The hands on time for loading 44 samples was practically the same for both systems, but for the follow-up tests the Milenia System is used next to the IMMULITE. Therefore from a logistical point of view the UniCAP System is more convenient. From these results we conclude that both logistically and clinically UniCAP seems to meet our requirements better than the IMMULITE.
More Related Videos
07:10Application of Biochip Microfluidic Technology to Detect Serum Allergen-specific Immunoglobulin E (sIgE)
Published on: April 21, 2019
06:50A High-Throughput Electrochemiluminescence 7-Plex Assay Simultaneously Screening for Type 1 Diabetes and Multiple Autoimmune Diseases
Published on: May 29, 2020